Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Return on Equity (2022 - 2026)

bioAffinity Technologies has reported Return on Equity over the past 5 years, most recently at 0.03% for Q1 2026.

  • Quarterly Return on Equity rose 2.0% to 0.03% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.03% through Mar 2026, up 2.0% year-over-year, with the annual reading at 0.03% for FY2025, 1.0% down from the prior year.
  • Return on Equity was 0.03% for Q1 2026 at bioAffinity Technologies, down from 0.02% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.34% in Q2 2025 and troughed at 0.05% in Q1 2025.
  • The 5-year median for Return on Equity is 0.02% (2024), against an average of 0.01%.
  • Year-over-year, Return on Equity decreased -4bps in 2023 and then soared 36bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.01% in 2022, then tumbled by -94bps to 0.01% in 2023, then crashed by -136bps to 0.03% in 2024, then skyrocketed by 42bps to 0.02% in 2025, then tumbled by -58bps to 0.03% in 2026.
  • Per Business Quant, the three most recent readings for BIAF's Return on Equity are 0.03% (Q1 2026), 0.02% (Q4 2025), and 0.04% (Q3 2025).